WOBURN, Mass., Aug. 28 /PRNewswire/ -- Surgical Sealants, Inc. (SSI) a
privately held company and a leader in the development of sealants and
adhesives that eliminate fluid and air leaks in complex surgical procedures,
will present at the upcoming Emerging Medical Technologies conference on
September 6 at 11:10 AM. The company will outline their product line and
answer questions following the presentation.
SSI has developed proprietary medical devices to seal fluid and air leaks
in complex surgical procedures. The first four products address problems
encountered in thoracic, vascular, general & neurosurgery. The company's
focus is on the medical sealants and adhesives market, estimated by
independent research to exceed $2.4 billion in the next five years. The
current market size is roughly $400 million and is dominated by fibrin glue.
Sealants typically have better adhesive qualities than fibrin glue and resist
pressure in a variety of clinical applications. The need for specialized
sealants, which effectively seal persistent leaks of air, blood and body
fluids, is large; translating into lower over-all costs and improved patient
outcomes. This is a rapidly emerging market that generally complements
sutures and staples and, in some cases, replaces them. Sealant technologies
are expected to be a significant factor in minimally invasive procedures as
the technology gains market acceptance.
SSI has a competitive advantage in the design and delivery of its
products, which ensures a leading position in this growing market. SSI has
proprietary technology and a unique competence in developing sealants that
adhere to various tissues and synthetic materials. In addition, the Company
has the expertise and capacity to manufacture these products. SSI plans to
leverage these strengths through strategic marketing partners to penetrate the
global markets with the exception of the lung product in the U.S, which SSI
will market itself.
Surgical Sealants, Inc.
Jonathan Donaldson, Chairman
James Wilkie, President & CEO
(781) 937-8181
http://www.surgicalsealants.com
This news release contains forward-looking statements that are subject to
risks and uncertainties. Actual results may differ from expected results
discussed in these statements.
SOURCE Surgical Sealants, Inc.
 back to top
Related links:
http://www.surgicalsealants.com
CONTACT:
Jonathan Donaldson, Chairman, or James
Wilkie, President & CEO, +1-781-937-8181, both of Surgical
Sealants, Inc.
|
